{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:39:06Z","timestamp":1793209146545,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rap2a, a member of the small GTPase superfamily, belongs to Ras superfamily, and its function in cancer progression is still poorly understood. Our previous study indicated that the ectopic expression of Rap2a enhanced the migration and invasion ability of lung cancer cells. However, its expression and molecular mechanism on renal cell carcinoma (RCC) have not been characterized. This study explored the clinical significance and biological function of Rap2a in human RCC. The clinical relevance of Rap2a in RCC was evaluated by immunohistochemical staining using tissue microarray. Our data showed that Rap2a expression was dramatically increased in RCC tissues compared with normal renal tissues. The ectopic expression of Rap2a enhanced the migration and invasive ability of cancer cells. In contrast, downregulation of Rap2a inhibited cell invasion. Rap2a had no effect on the proliferation of RCC cell lines. Meanwhile, Rap2a can regulate the phosphorylation level of Akt <jats:italic>in vitro<\/jats:italic>. <jats:italic>In vivo<\/jats:italic> studies also showed that Rap2a positively regulated metastasis of renal cancer cells and the expression of p-Akt. These findings indicate that Rap2a promotes RCC metastasis and may serve as a candidate RCC prognostic marker and a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41598-017-06162-7","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T15:15:42Z","timestamp":1500563742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt"],"prefix":"10.1038","volume":"7","author":[{"given":"Jin-Xia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Cun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sheng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"6162_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.urolonc.2012.08.021","volume":"30","author":"WM Linehan","year":"2012","unstructured":"Linehan, W. M. & Rathmell, W. K. Kidney cancer. Urol oncol.30, 948\u2013951 (2012).","journal-title":"Urol oncol."},{"key":"6162_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan, W. M., Srinivasan, R. & Schmidt, L. S. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol.7, 277\u2013285 (2010).","journal-title":"Nat Rev Urol."},{"key":"6162_CR3","first-page":"305","volume":"21","author":"MW Ball","year":"2016","unstructured":"Ball, M. W., Allaf, M. E. & Drake, C. G. Recent advances in immunotherapy for kidney cancer. Discov Med.21, 305\u2013313 (2016).","journal-title":"Discov Med."},{"key":"6162_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/BJ20051086","volume":"394","author":"V Mittal","year":"2006","unstructured":"Mittal, V. & Linder, M. E. Biochemical characterization of RGS14: RGS14 activity towards G-protein alpha subunits is independent of its binding to Rap2A. Biochem J.394, 309\u2013315 (2006).","journal-title":"Biochem J."},{"key":"6162_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biochi.2005.08.007","volume":"88","author":"S Paganini","year":"2006","unstructured":"Paganini, S. et al. Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins. Biochimie.88, 285\u2013295 (2006).","journal-title":"Biochimie."},{"key":"6162_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/j.1460-2075.1993.tb05662.x","volume":"12","author":"CF Albright","year":"1993","unstructured":"Albright, C. F., Giddings, B. W., Liu, J., Vito, M. & Weinberg, R. A. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J.12, 339\u2013347 (1993).","journal-title":"EMBO J."},{"issue":"Pt 1","key":"6162_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/bj2890017","volume":"289","author":"GM Bokoch","year":"1993","unstructured":"Bokoch, G. M. Biology of the Rap proteins, members of the ras superfamily of GTP-binding proteins. Biochem J.289(Pt 1), 17\u201324 (1993).","journal-title":"Biochem J."},{"key":"6162_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1006\/bbrc.1994.1139","volume":"198","author":"E Pasheva","year":"1994","unstructured":"Pasheva, E., Janoueix-Lerosey, I., Tavitian, A. & de, Gunzburg, J. Characterization of the Ras-related RAP2A protein expressed in the baculovirus-insect cell system: processing of the protein in insect cells and comparison with the bacterially produced unprocessed form. Biochem Biophys Res Commun.198, 973\u2013982 (1994).","journal-title":"Biochem Biophys Res Commun."},{"key":"6162_CR9","first-page":"643","volume":"17","author":"J Wu","year":"2014","unstructured":"Wu, J., Sang, M., Cao, W., Zheng, J. & Pei, D. Identification analysis of eukaryotic expression plasmid Rap2a and its effect on the migration of lung cancer cells. Zhongguo Fei Ai Za Zhi.17, 643\u2013648 (2014).","journal-title":"Zhongguo Fei Ai Za Zhi."},{"key":"6162_CR10","first-page":"912","volume":"7","author":"YE Lee","year":"2015","unstructured":"Lee, Y. E. et al. The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area. Am J Transl Res.7, 912\u2013921 (2015).","journal-title":"Am J Transl Res."},{"key":"6162_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cellsig.2015.02.026","volume":"27","author":"JX Wu","year":"2015","unstructured":"Wu, J. X., Zhang, D. G., Zheng, J. N. & Pei, D. S. Rap2a is a novel target gene of p53 and regulates cancer cell migration and invasion. Cell Signal.27, 1198\u20131207 (2015).","journal-title":"Cell Signal."},{"key":"6162_CR12","doi-asserted-by":"publisher","first-page":"13406","DOI":"10.1074\/jbc.C000085200","volume":"275","author":"JF Rebhun","year":"2000","unstructured":"Rebhun, J. F., Chen, H. & Quilliam, L. A. Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral. J Biol Chem.275, 13406\u201313410 (2000).","journal-title":"J Biol Chem."},{"key":"6162_CR13","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1164\/ajrccm\/142.6_Pt_2.S27","volume":"142","author":"S Rodenhuis","year":"1990","unstructured":"Rodenhuis, S. & Slebos, R. J. The ras oncogenes in human lung cancer. Am Rev Respir Dis.142, S27\u2013S30 (1990).","journal-title":"Am Rev Respir Dis."},{"key":"6162_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.bjc.6602258","volume":"92","author":"C Mascaux","year":"2005","unstructured":"Mascaux, C. et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer.92, 131\u2013139 (2005).","journal-title":"Br J Cancer."},{"key":"6162_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1073858410365562","volume":"17","author":"RL Stornetta","year":"2011","unstructured":"Stornetta, R. L. & Zhu, J. J. Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist.17, 54\u201378 (2011).","journal-title":"Neuroscientist."},{"key":"6162_CR16","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1158\/0008-5472.CAN-08-4269","volume":"69","author":"CL Bailey","year":"2009","unstructured":"Bailey, C. L., Kelly, P. & Casey, P. J. Activation of Rap1 promotes prostate cancer metastasis. Cancer Res.69, 4962\u20134968 (2009).","journal-title":"Cancer Res."},{"key":"6162_CR17","doi-asserted-by":"publisher","first-page":"49488","DOI":"10.1074\/jbc.M406370200","volume":"279","author":"K Taira","year":"2004","unstructured":"Taira, K. et al. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton. J Biol Chem.279, 49488\u201349496 (2004).","journal-title":"J Biol Chem."},{"key":"6162_CR18","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/pros.20644","volume":"67","author":"D Bigler","year":"2007","unstructured":"Bigler, D., Gioeli, D., Conaway, M. R., Weber, M. J. & Theodorescu, D. Rap2 regulates androgen sensitivity in human prostate cancer cells. Prostate.67, 1590\u20131599 (2007).","journal-title":"Prostate."},{"key":"6162_CR19","doi-asserted-by":"publisher","first-page":"979840","DOI":"10.4061\/2011\/979840","volume":"2011","author":"I Prabakaran","year":"2011","unstructured":"Prabakaran, I., Grau, J. R., Lewis, R., Fraker, D. L. & Guvakova, M. A. Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer. J Thyroid Res.2011, 979840 (2011).","journal-title":"J Thyroid Res."},{"key":"6162_CR20","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/cam4.754","volume":"5","author":"T Fukuda","year":"2016","unstructured":"Fukuda, T. et al. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma. Cancer Med.5, 1810\u20131820 (2016).","journal-title":"Cancer Med."},{"key":"6162_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","volume":"281","author":"WH Chow","year":"1999","unstructured":"Chow, W. H., Devesa, S. S., Warren, J. L. & Fraumeni, J. F. Jr. Rising incidence of renal cell cancer in the United States. JAMA.281, 1628\u20131631 (1999).","journal-title":"JAMA."},{"key":"6162_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13256-016-0961-0","volume":"10","author":"K Ueda","year":"2016","unstructured":"Ueda, K. et al. Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report. J Med Case Rep.10, 177 (2016).","journal-title":"J Med Case Rep."},{"key":"6162_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa060655","volume":"356","author":"B Escudier","year":"2007","unstructured":"Escudier, B. et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med.356, 125\u2013134 (2007).","journal-title":"N Engl J Med."},{"key":"6162_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa066838","volume":"356","author":"G Hudes","year":"2007","unstructured":"Hudes, G. et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med.356, 2271\u20132281 (2007).","journal-title":"N Engl J Med."},{"key":"6162_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa065044","volume":"356","author":"RJ Motzer","year":"2007","unstructured":"Motzer, R. J. et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med356, 115\u2013124 (2007).","journal-title":"N Engl J Med"},{"key":"6162_CR26","doi-asserted-by":"publisher","first-page":"29359","DOI":"10.18632\/oncotarget.8833","volume":"7","author":"S Yin","year":"2016","unstructured":"Yin, S. et al. Wip1 suppresses ovarian cancer metastasis through the ATM\/Akt\/Snail mediated signaling. Oncotarget.7, 29359\u201329370 (2016).","journal-title":"Oncotarget."}],"updated-by":[{"DOI":"10.1038\/s41598-021-93823-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06162-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06162-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06162-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:35:13Z","timestamp":1671780913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06162-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6162"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06162-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"assertion":[{"value":"31 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-93823-3","URL":"https:\/\/doi.org\/10.1038\/s41598-021-93823-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6623"}}